|4Jan 3, 5:19 PM ET

Adler Reid G. 4

4 · Vistagen Therapeutics, Inc. · Filed Jan 3, 2024

Insider Transaction Report

Form 4
Period: 2023-12-29
Adler Reid G.
Chief Legal Officer
Transactions
  • Award

    Common Stock

    2023-12-29$1.72/sh+167$28711,655 total
Footnotes (1)
  • [F1]Shares purchased pursuant to the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan.

Documents

2 files